Document is current
Any future updates will be listed below
-
Authors
Chiozzi, Paola
Sarti, Alba Clara
Sanz, Juana M.
Giuliani, Anna Lisa
Adinolfi, Elena
Vultaggio-Poma, Valentina
Falzoni, Simonetta
Di Virgilio, Francesco https://orcid.org/0000-0003-3566-1362
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 16812)
Associazione Italiana per la Ricerca sul Cancro (IG 13025)
Associazione Italiana per la Ricerca sul Cancro (IG 18581)
European Cooperation in Science and Technology (BM1406)
- License Information
-
More Information
Article History
Received: 17 January 2019
Accepted: 11 April 2019
First Online: 24 April 2019
Competing Interests
: F.D.V. is a member of the Scientific Advisory Board of Biosceptre Ltd, a UK-based Company involved in the development of P2X7-targeted antibodies, and has an ongoing collaboration with Ablynx, a Belgian Company involved in the development of P2X7R-targeted nanobodies. Other Authors declare no conflict of interest.
